ZRO Biosenta Inc

Biosenta and University of Calgary Research Group launch anti-microbial, nanoparticle development partnership

Biosenta and University of Calgary Research Group launch anti-microbial, nanoparticle development partnership

TORONTO, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) listed on the CSE (CSE: ZRO) is pleased to announce the finalization of a four-year research partnership with the University of Calgary.

Biosenta has wasted no time in creating innovation in Alberta. A research partnership with the University of Calgary Research Group and AMPAK Inc. from Toronto, Ontario, is official.

This partnership enables the University team to undertake a new generation of research in the world of nanoparticles for use as an anti-microbial filler in commercial construction materials and plastic consumer products and goods packaging.

The University of Calgary team has demonstrated expertise in this field, previously improving the tensile strength of concrete by 80%. The University of Calgary team has also improved the performance of drilling fluids and ceramic membranes using nanoparticle technology.

AMPAK Inc. is proud to be the first Industry research partner to commit to the project. The scope of AMPAK’s involvement includes plastic product development, research and development, and commercial consumer packaging.

The partnership’s goal is to synthesize nanoscale core-shell particles and standardize the production process of Biosenta’s patented two-part, food-grade nanoparticles called Tri-filler. Tri-filler not only has attributes of being anti-microbial, but also strength enhancement and fire-retardant capabilities.

This innovation has the potential to revolutionize the antiviral properties of everyday surfaces such as clothes, paint, drywall, concrete, common surfaces and consumer packaging materials.

“The end goal is to create anti-viral materials used for everyday construction and packaging. An anti-microbial compound that can resist or destroy germs, viruses, fungi, and bacteria on its surface, better protects everyone.”

- Dr. Maen Husein, Project Principal, Professor, Chemical Engineering   

The project principal is actively looking to engage with businesses or commercial entities seeking to improve their products’ and materials’ anti-microbial properties.

The impact on the community is measurable and two-fold. Firstly, there is an incredible opportunity for local organizations that currently use nanoparticles as fillers to get involved in development and testing activities as research partners.

Secondly, the University team has dedicated a significant portion of their efforts to measuring nanoparticles’ impact on human health and their concentration levels within the body over time due to consistent exposure, even at minimal parts-per-million.

The University team is implementing theories to safely integrate the nanoparticles within compounds to improve end-user safety and increase the filler’s usability in multiple consumer applications.

Am Gill, President and CEO of Biosenta, said, “After years of dedicated research in the anti-microbial space, we are very excited to finalize this research partnership with one of the top educational institutes globally. We are also in talks with additional industry partners in cement and paint, to exploit the innovation and test Tri-filler in their production processes in addition to AMAPK Inc. These are inspiring times for Biosenta.”

About Biosenta Inc.

Biosenta Inc. Develops and manufactures a range of wet and dry chemical compounds for household and industrial applications using advanced encapsulated nanotechnology. Biosenta disinfectants and cleaners kill 99.9% of mold, fungi, bacteria and viruses on contact and prevent re-growth. Biosenta disinfectants are safe for consumer use with low levels of active ingredients.

Biosenta industrial compounds are embedded to protect various materials from microbial threats and prevent the growth of harmful viruses and bacteria on their surfaces, including drywall, plastic and resins.

These compounds remain active for decades and protect the walls of buildings, resin furniture, a carpet rubber backing, synthetic tufts that contain plastic or resin, textiles and paper from mold, fungi, bacteria and viruses. 

Disclaimer

In no way, the CSE has passed upon the contents of this news release and further has neither approved nor disapproved of the contents of this news release. Neither the CSE nor it's Regulation Services Provider (as such term is defined in the CSE) accepts responsibility for this release's adequacy or accuracy.

Biosenta Digital channel:

Contact Information:

Am Gill

President and CEO

T: 416-410-2019

For further information on the project,

please contact: 







Sales

Biosenta Inc.

34 Wrangler Place, Suite 10

Rocky View County, Alberta T1X 0L7

T: 416-410-2019

E:
For Investor Relations, 

please contact: 







Investor Relations

Biosenta Inc.

18 Wynford Drive, Suite 704

Toronto, Ontario M3C 3S2

T: 416-410-2019

E:
 

 

EN
24/09/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Biosenta Inc

 PRESS RELEASE

Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy o...

Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Filler™ in Collaboration with Dr. Ian Lewis and Dr. Maen Husein's Labs TORONTO and CALGARY, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) (CSE: ZRO) is thrilled to announce a pivotal discovery led by Dr. Mehdi Mohammadi Ashani, a Postdoctoral Researcher under the mentorship of Dr. Ian Lewis and Dr. Maen Husein at the University of Calgary. Utilizing the advanced capabilities of the Alberta Centre for Advanced Diagnostics (ACAD), this research has revealed that Tri-Filler™,...

 PRESS RELEASE

Biosenta builds on partnership with AMPAK to test and commercialize Tr...

Biosenta builds on partnership with AMPAK to test and commercialize Tri-Filler™ CALGARY, Alberta, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) listed on the CSE (CSE: ZRO) is pleased to announce the next level of partnership with AMPAK Inc. and the University of Calgary. The new Agreement will see Tri-Filler™ being tested in plastics at AMPAK Inc. facilities with an eye to commercialization. Further to the announcement of the partnership on September 24th, 2020, AMPAK Inc. has signed a new agreement with Biosenta and the University of Calgary that will g...

 PRESS RELEASE

Biosenta announces further advances in research and development of Tri...

Biosenta announces further advances in research and development of Tri-Filler™ TORONTO and CALGARY, Alberta, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) (CSE: ZRO) is pleased to announce further advances in research and development of the Tri-Filler™ particle composed of Ca(OH)2 (calcium hydroxide) core with a CaCO3 (calcium carbonate) encapsulation. Ongoing development of new methods of production of Tri-Filler™ by Dr. Maen Husein of the Department of Chemical Engineering at the University of Calgary and his team have reduced aggregation and resulted in ...

 PRESS RELEASE

Biosenta Inc. ceases negotiations with Voran Group Ventures Ltd.

Biosenta Inc. ceases negotiations with Voran Group Ventures Ltd. CALGARY, Alberta, May 31, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. ( “Biosenta”) (CSE: ZRO) announces that, further to its news release dated October 12, 2022, it has ceased negotiations with Voran Group Ventures Ltd. in respect of the previously announced Memorandum of Understanding dated October 5, 2022, for the commercialization of Biosenta’s Tri-Filler® antimicrobial products in Canadian markets and worldwide. About Biosenta Inc. Biosenta is a Canadian-based company that develops and manufactures a range of safe and envi...

 PRESS RELEASE

Biosenta Inc. Enters into an MOU with Voran Group Ventures Ltd. to col...

Biosenta Inc. Enters into an MOU with Voran Group Ventures Ltd. to collaborate on the commercialization of Biosenta’s Tri-Filler® Products CALGARY, Alberta, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Biosenta Inc. (the “Company” or “Biosenta”) (CSE: ZRO) has signed a milestone Memorandum of Understanding dated October 5, 2022, with VORAN GROUP VENTURES Ltd. (“Voran”) which will lead the way for the commercialization of Biosenta’s Tri-Filler® antimicrobial products in Canadian markets and worldwide. The patented new material science Tri-Filler® products could set the new standard in antimicrobial ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch